Watch for Gallbladder Problems in Patients Using GLP-1 Agonists

You'll hear more about a possible link between gallbladder disease and GLP-1 agonists...such as Victoza (liraglutide) or Byetta (exenatide).

The latest evidence suggests that about one in 357 patients on liraglutide or exenatide over about 3 years will be hospitalized for bile duct or gallbladder disease...compared to patients on other diabetes meds.

Patients with diabetes already have a higher risk of bile duct and gallbladder disease. But GLP-1 agonists may increase this risk...possibly by causing rapid weight loss in some patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote